Evidence map›Paper›PMID 34286289›Full record

ArticleSTAR protocols2021

Protocols for assessing neurodegenerative phenotypes in Alzheimer's mouse models.

Jongkyun Kang, Hirotaka Watanabe, Jie Shen

Abstract read
In one paragraph

Article in STAR protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Journal of experimental pharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Cortical neurodegeneration caused byProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Motor Impairments and Dopaminergic Defects Caused by Loss of Leucine-Rich Repeat Kinase Function in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jongkyun KangDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Hirotaka WatanabeDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Jie ShenDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Funding

Role of Presenilins in the SynapseR01NS041783 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Jie Shen · 2001 to 2026
$10.6M
LRRK in Autophagy Function and Dopaminergic Neuron SurvivalR37NS071251 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHEN, JIE · 2015 to 2021
$4.5M
Development of novel therapies for FADRF1AG063520 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHEN, JIE · 2019 to 2019
$3.9M
Identification of Presinilin downstream targets in neuronal survivalR01NS101745 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI PERRIMON, NORBERT, SHEN, JIE · 2017 to 2021
$3.6M
Presenilin and APP in the BrainRF1NS041783 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHEN, JIE · 2021 to 2021
$2.7M
NIA NIH HHS RF1 AG063520NINDS NIH HHS R01 NS041783NINDS NIH HHS R01 NS101745NINDS NIH HHS R37 NS071251NINDS NIH HHS RF1 NS041783
6 · The paper itself

Abstract

Quantitative assessment of neuropathological changes is essential for the characterization of animal models of neurodegenerative disease. Here, we describe a detailed protocol for the detection and quantification of key neuropathological changes in Alzheimer's mouse models. The protocol covers detailed methods including perfusion, dissection, and paraffinization of the brain, preparation of serial brain sections, immunohistochemical analysis, stereological quantification, and sample coding methods for genotype blind analysis. This protocol may be applied to the analysis of neuropathological changes of other neurological disorders. For complete details on the use and execution of this protocol, please refer to Lee et al. (2020), Kang and Shen (2020), Giaime et al. (2017), Xia et al. (2015), Watanabe et al. (2012, 2014), Wines-Samuelson et al. (2010), and Saura et al. (2004).

Indexed as

Alzheimer DiseaseAnimalsApoptosisBrainDisease Models, AnimalFemaleGliosisHistological TechniquesMaleMiceNeuropathologyPhenotypeMicrobiologyModel OrganismsNeuroscience

Identifiers

PMID34286289
PMCPMC8273404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.